American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 8(62), 2018
DOI: 10.1128/aac.01031-18
Full text: Unavailable
Carbapenem-resistant and hypervirulent Klebsiella pneumoniae (CR-hvKp) strains have emerged while antimicrobial treatment options remain limited. Herein, we tested the in vitro activity of ceftazidime-avibactam and other comparator antibiotics against 65 CR-hvKp isolates.